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ince 1976 the Toxic Substances Control
Act (TSCA) has given the federal govern-
ment the power to require that chemicals
are properly tested and regulated before they
reach the market, and that they don’t pose unrea-
sonable risks to human and environmental
health. TSCA is the key piece of legislation gov-
erning the way the U.S. Environmental Protec-
tion Agency (EPA) reviews and regulates chemi-
cals including solvents and constituents of paints,
fuels, and plastics. Yet, concerns persist about
chemical safety and the adequacy of regulation.
Now, in a June 2005 report titled Chemical
Regulation: Options Exist to Improve EPA’s Ability
to Assess Health Risks and Manage Its Chemical
Review Program, the Government Accountability
Office (GAO) has reviewed the EPA’s efforts to
control the risks of new chemicals not yet in
commerce, to assess the risks of existing chemicals
used in commerce, and to publicly disclose infor-
mation provided by chemical companies under
TSCA. The report points out shortcomings in
TSCA and its implementation, and suggests ways
to strengthen the law. 
HPV Chemicals
TSCA authorized the EPA to both assess new
chemicals before they enter the marketplace and to
review chemicals already on the market. But when
the law was enacted, thousands of chemicals
already being used were grandfathered in. “Those
sixty-two thousand or so chemicals were just
accepted as being okay to be in commerce without
any kind of EPA risk analysis,” says David
Bennett, the report’s lead analyst. 
Even aside from these grandfathered chemicals,
the EPA has an enormous number of chemicals to
examine, so the agency has narrowed its approach.
“We have decided to focus our work on the high-
volume chemicals, using volume as a surrogate for
[human and environmental] exposure,” says
Charles Auer, director of the EPA Office of
Pollution Prevention and Toxics. The High
Production Volume (HPV) Challenge Program
was started in 1998 with the goal of looking at
some 2,800 chemicals that were produced in quan-
tities exceeding 1 million pounds per year as of
1990. The voluntary program was established by
the EPA, Environmental Defense, the American
Chemistry Council (ACC), and the American
Petroleum Institute to identify and fill gaps in
basic hazard data for these chemicals, and to make
those data publicly available by 2005. 
The information garnered from the HPV
Challenge Program “will allow us to prioritize
among the chemicals and then obtain additional
information where appropriate or take control
actions,” says Auer. Michael P. Walls, managing
director of health, products, and science policy at
the ACC, adds, “Through the [HPV Challenge]
Program we provide a mechanism to assure the
agency that there is adequate information on
which to base current risk management decisions.” 
“The program is a light-some-candles-rather-
than-sit-and-curse-the-darkness initiative,” says
Karen Florini, a senior attorney with Environ-
mental Defense. “It gathers preliminary basic
screening-level information. It’s clearly valuable;
it’s just limited.”
Despite progress made to date, the GAO
report states there are 300 chemicals in the HPV
Challenge Program “for which chemical compa-
nies have not agreed to provide the minimal test
data that EPA believes are needed to initially assess
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 their risk.” Auer regards that situation as
“unfinished business.” He says the EPA is
developing rules to require industry to test
those chemicals. “We hope to finalize that
test rule at the end of this year or early next
year,” he says.
Both Auer and Walls note there could
be a variety of reasons for the chemical
industry not doing this testing voluntarily.
For example, in some instances domestic
manufacturers of a chemical have said they
would be willing to provide information
only if foreign competitors who export the
chemical to the United States would share
the cost of testing—support that was not
forthcoming. However, once a test rule is in
effect, anyone who produces or imports the
chemical must comply and provide the data. 
New Chemicals
The GAO report also voices concern about
the EPA’s efforts to regulate new chemi-
cals. Though the report noted that the EPA
has taken actions to regulate exposure to
about 3,500 of 32,000 new chemicals sub-
mitted for review since TSCA was enacted,
the GAO has qualms about the way in
which those chemicals were examined.
The EPA typically does not have
enough data on a submitted chemical’s
properties to determine its toxicity.
Consequently, it may compare a new
chemical with closely related model chemi-
cals to predict whether the new compound
will pose a safety hazard. “We found evi-
dence that in some cases the models were
not entirely predictive. The problem is that
in some cases there is just not a lot of data
out there to show how predictive the mod-
els are,” says Bennett.
Auer counters that the models do what
they are supposed to—identify potentially
hazardous candidates for further testing.
He adds that the models also tend to err
on the side of caution—that is, they tend
to identify chemicals that appear to be haz-
ardous but prove to be safe upon further
examination.
The GAO report also notes that TSCA
does not require chemical companies to
submit data to the EPA on the toxicity,
routes of exposure, or potential extent of
exposure of new chemicals. “I think it is
scandalous that new chemicals can be
brought to market without being accompa-
nied by any actual data,” Florini says.
“Eighty-five percent of PMNs [premanu-
facture notices, which must be submitted
to the EPA at least 90 days before produc-
tion of a new chemical begins] are submit-
ted with no health data, and reliable models
aren’t available for many end points, partic-
ularly for long-term health effects other
than cancer.”
But Walls says chemical manufacturers
must be prepared to supply data to the
EPA if a chemical has characteristics of
persistence, bioaccumulation, and toxicity.
“The assumption that new chemical appli-
cations are filed in the United States with
no information is not right,” he says. He
agrees that TSCA does not require safety
and exposure data, but adds that if a com-
pany is submitting a chemical to which
people could be exposed, the company
would be “remiss” in not providing that
information. Still, the data need be provid-
ed only if the agency asks for them. 
Auer asserts that requiring toxicity test-
ing before a chemical is actually manufac-
tured, as required by TSCA, could interfere
with innovation in the industry. He esti-
mates the cost of providing the information
wanted by the EPA to be in the range of a
quarter of a million dollars for new chemi-
cals. Auer says the expense of testing before
a chemical company knows whether there
will be a demand for a chemical could hob-
ble efforts to develop improved chemicals,
and maintains that the EPA’s track record
of taking action to reduce the risk of new
chemicals is a good one.
TSCA, Take Two
Faced with the lack of required data for
new chemicals and what the GAO regards
as the uncertain effectiveness of the volun-
tary HPV Challenge Program, the report
recommends that Congress give the EPA
the authority to require chemical manufac-
turers to generate and provide test data on
HPV chemicals. That recommendation is
embodied in legislation introduced in
Congress this summer by senators Frank
Lautenberg (D–NJ) and James Jeffords
(I–VT). The bill also would give the EPA
the authority to require those data for all
chemicals used, and to prioritize which
chemicals the industry would have to test.
Auer says the EPA has not yet taken a posi-
tion on the bill. Environmental Defense
supports it, while the ACC opposes it, say-
ing it duplicates the EPA’s existing author-
ity under TSCA.
The GAO offers a number of other
recommendations to strengthen the act.
Among them are validating and improving
the models used by the EPA to assess risks
of chemicals; requiring chemical compa-
nies to submit testing results of chemicals
with PMNs; letting the EPA regulate
chemicals if they pose a “significant” risk
to health or the environment rather than
the more stringent “unreasonable” risk;
and setting national goals for reducing the
overall use of toxic chemicals. 
Auer says the EPA will soon have
much better exposure information under
amendments to the TSCA Inventory
Update Rule, which requires chemical
manufacturers to submit basic production
data every four years for chemical sub-
stances (including imports) manufactured
for commercial purposes in amounts of
25,000 pounds or more at a single site.
According to the EPA, the 2003 amend-
ments tailor reporting requirements to
more closely match the EPA’s information
needs, provide a vehicle for the EPA to
obtain updated information on the poten-
tial human and environmental exposures
of chemical substances listed on the TSCA
Inventory, and improve the utility of the
information reported under the rule.
With the amendments, “we will know
the chemicals that are in consumer prod-
ucts,” Auer says. “We will know the number
of workers that are exposed to chemicals.
We will have a better basic idea of the uses
of chemicals. So EPA in sixteen months
will have basic exposure information on
[HPV] chemicals.”
Moreover, Auer says the EPA will
require the information to be updated
every five years so the agency can under-
stand how chemical use is shifting and
whether safer alternatives have been devel-
oped in the meantime. He says the infor-
mation will allow the EPA to identify
HPV chemicals that are candidates for
more testing or for enhanced regulation.
Further, Walls says the chemical industry
on its own initiative will supply the EPA
with hazard data on around 500 chemicals
that reached the high-volume threshold
between 1990 and 2002.
Nevertheless, Bennett reserves judg-
ment on the HPV Challenge Program’s
effectiveness. “The process is ongoing, so I
would hesitate to say how successful it is,
because EPA has not received all the data
that industry has promised to deliver. We
won’t know for some time whether the
program will be successful,” he says.
Florini echoes that view, and also
points out that the EPA is “way behind”
in making public the information submit-
ted to date. “Six years into the HPV
Challenge Program, it’s really regrettable
that the database hasn’t yet been released,
though it apparently will be out by year-
end,” she says.
After three decades of existence, it is
appropriate that TSCA is undergoing sig-
nificant examination, as the EPA, the
chemical industry, environmentalists, and
legislators all look at ways to revise this
major statute. What a revised TSCA will
look like after this examination, however,
is far from certain. 
Harvey Black
A 830 VOLUME 113 | NUMBER 12 | December 2005 • Environmental Health Perspectives
Spheres of Influence | GAO Sounds OffLinking
Lessons
Learning
Tomorrow’s Scientists
EHP can help you give your students the tools to succeed.
For more information on the EHP Student Edition and Lesson Program 
log on today at www.ehponline.org/science-ed.
ehp